| Literature DB >> 30696826 |
Pavel Katsel1, Panos Roussos2,3,4, Peter Fam4, Sonia Khan2, Weilun Tan2, Tetsuro Hirose5, Shinichi Nakagawa5,6, Mikhail V Pletnikov7, Vahram Haroutunian2,4,8.
Abstract
Oligodendrocyte (OLG)-related abnormalities have been broadly observed in schizophrenia (SZ); however, the etiology of these abnormalities remains unknown. As SZ is broadly believed to be a developmental disorder, the etiology of the myelin abnormalities in SZ may be related to OLG fate specification during development. Noncoding RNAs (ncRNAs) are an important part of multifaceted transcriptional complexes participating in neurogenic commitment and regulation of postmitotic cell function. The long ncRNA, NEAT1, is a structural component of paraspeckles (subnuclear bodies in interchromatin regions) that may control activity of developmental enhancers of OLG fate specification. Gene expression studies of multiple cortical regions from individuals with SZ showed strong downregulation of NEAT1 levels relative to controls. NEAT1-deficient mice show significant decreases in the numbers of OLG-lineage cells in the frontal cortex. To gain further insight into biological processes affected by NEAT1 deficiency, we analyzed RNA-seq data from frontal cortex of NEAT1-/- mice. Analyses of differentially expressed gene signature from NEAT1-/- mice revealed a significant impact on processes related to OLG differentiation and RNA posttranscriptional modification with the underlying mechanisms involving Wnt signaling, cell contact interactions, and regulation of cholesterol/lipid metabolism. Additional studies revealed evidence of co-expression of SOX10, an OLG transcription factor, and NEAT1, and showed enrichment of OLG-specific transcripts in NEAT1 purified chromatin isolates from human frontal cortex. Reduced nuclear retention of quaking isoform 5 in NEAT1-/- mice shed light on possible mechanism(s) responsible for reduced expression of OLG/myelin proteins and supported the involvement of NEAT1 in oligodendrocyte function.Entities:
Year: 2019 PMID: 30696826 PMCID: PMC6386752 DOI: 10.1038/s41537-019-0071-2
Source DB: PubMed Journal: NPJ Schizophr ISSN: 2334-265X
Fig. 1Gene expression changes of total NEAT1 and long isoform NEAT1_22.7 K in 17 brain regions in schizophrenia. Cortical Brodmann areas are marked. HIPP hippocampus, CD caudate, PT putamen. Data are expressed as mean ± SEM. Diagnosis effects are summarized in Tables S3 and S4
Fig. 2Neat1 is expressed in OLGs and its knockout affects forebrain OLG-lineage cells. a Bright-field images of Neat1 and Sox10 ISH in murine striatum. Inserts from the frame: Fluorescent ISH for Neat1 and Sox10. Cell nuclei were counterstained with DAPI. The scale bars, 10 µm. Lower panel: Neat1-/- mice show depleted Neat1 expression. b Fluorescent ISH for NEAT1 and SOX10 in human cingulate cortex (BA32). OLGs nuclei colocalization of NEAT1 and SOX10 is marked by arrowheads. Scale bars are 20 (upper) and 10 (lower) µm. c Flow cytometry scatter plots and analysis of Olig2+ and NeuN+ labeled cells from forebrains of controls, Neat1-/-, and Qke5 mice. Data are expressed as mean ± SEM (N = 5/group). ***Student’s two-tailed t-test; p < 0.001
Fig. 3Differential gene expression analysis in frontal cortex of Neat1-/- mice. a PCA of gene expression in frontal cortex between control (red) and Neat1-/- (blue) mice. b Hierarchical cluster tree of RNA-seq samples shows separate clustering of samples from Neat1-/- mice (N = 4) and controls (N = 5). c Volcano plot of mRNA expression. The DEGs located in Neat1 genomic region are marked. d, e DEGs in mouse (chr.19) and human (chr.11q13.1) genomic loci of NEAT1 from Neat1-/- mice and in SZ. Genes are organized based on the chromosome location, centered on NEAT1. Parentheses signs indicate DNA strand of transcription. Data are summarized in Tables S5–S6. Homologous genes are marked in bold (blue-downregulated; red-upregulated). f Hierarchical cluster tree of module’s eigengenes (top) co-expression network in murine frontal cortex and the topological overlap matrix (TOM) plot. The rows and columns represent the same set of genes sorted by the hierarchical clustering tree of TOM with modules represented by colored labels. The top affected modules highlighted by the rectangle. g Top affected modules associations with Neat1 deletion. Numbers correspond to Pearson’s correlation (green to red gradient) and p-values (in brackets)
Fig. 4Neat1 expression is associated with OLG-specific markers. a Volcano plot of mRNA expression in frontal cortex of NEAT1-/- compared with controls. The OLG-specific[66] DEGs are highlighted (red) and labeled (yellow). b Heatmap showing gene expression of affected genes influencing OLG differentiation in Neat1-/- and SZ. Scale indicates expression relative to their appropriate controls; t-scores and p-values are shown in Table 1. c Ratio plots (fold change ± SEM) of mRNA levels of OLG-specific genes, in the frontal cortex and white matter of Qkie5 and Neat1-/- mice as determined by qPCR analyses (n = 6/group for Qkie5 and n = 5/group for Neat1-/-). Insert plot shows ratios for Pspc1 and Neat1 in Qkie5 mice. d Immunofluorescence staining of Qki-5 in the forebrain of controls and Neat1-/- mice. Cell nuclei were counterstained with DAPI. Scale bar, 10 µm. Immunostaining was repeated on nine sections from two independent animals from each experimental group. Fluorescence measurements in outlined DAPI-stained nuclei were performed using ImageJ 1.50b software (Wayne Rasband, NIH, USA) on six adjacent sections for each animal. Data are expressed as mean ± SEM. ***Student’s two-tailed t-test; p < 0.001; **p < 0.01; *p < 0.05
OLG differentiation category (magenta module; Fig. 4b) affected genes in frontal cortex of Neat1-/- mice identified by IPA
| Symbol | Gene name |
|
| ||
|---|---|---|---|---|---|
|
| Oligodendrocyte transcription factor 1 | −4.79 | 4.2E − 04 | −1.29 | NS |
|
| Neurofascin | −4.34 | 9.4E−04 | −8.12 | 8.9E − 13 |
|
| Oligodendrocyte transcription factor 2 | −4.27 | 0.001 | −2.86 | 6.1E − 03 |
|
| Ectonucleotide pyrophosphatase/ phosphodiesterase 2 | −3.41 | 0.005 | −4.49 | 7.8E − 08 |
|
| G protein-coupled receptor 17 | −3.16 | 0.008 | −0.35 | NS |
|
| Inhibitor of DNA binding 4, HLH protein | −2.74 | 0.018 | −3.61 | 1.2E − 04 |
|
| erb-b2 receptor tyrosine kinase 3 | −2.36 | 0.036 | −4.05 | 1.1E − 04 |
|
| Tenascin C | −2.33 | 0.038 | −1.97 | NS |
|
| Tetraspanin 2 | −2.30 | 0.040 | 0.39 | NS |
|
| SRY-box 8 | −2.30 | 0.040 | −1.92 | 0.010 |
|
| SWI/SNF related, matrix associated, regulator of chromatin, subfamily a, member 4 | −2.29 | 0.040 | 3.35 | 0.008 |
|
| Transient receptor potential cation channel subfamily C member 4 | −2.23 | 0.045 | −1.76 | NS |
|
| Gap junction protein gamma 2 | −2.11 | 0.050 | 0.55 | NS |
|
| SRY-box 5 | 2.28 | 0.041 | −0.92 | NS |
|
| Fibroblast growth factor receptor 3 | 2.98 | 0.011 | 0.45 | NS |
|
| Inhibitor of DNA binding 2, HLH protein | 5.18 | 2.2E − 04 | −2.89 | 0.017 |
Corresponding t-scores across 17 cortical regions from individuals with SZ derived from microarray dataset (see Methods)
aSZ p-values are from moderated t-test with Benjamini and Hochberg multiple testing corrections. NS nonsignificant